Welgene Biotech Co.,Ltd. (TPEX:6661)
18.60
-0.50 (-2.62%)
At close: Feb 11, 2026
Welgene Biotech Company Description
Welgene Biotech Co.,Ltd. engages in the trade of biotechnology-related instruments, reagents, and biotechnology testing services.
The company offers research services, including generation, PacBio third generation sequencing; microarray, protein body analysis; nucleic acid extraction/QC, single cell experimental, and bioinformatics analysis services.
It also provides reagents, medical consumables, and instruments, as well as software services. Welgene Biotech Co.,Ltd. was founded in 2003 and is based in Taipei City, Taiwan.
Welgene Biotech Co.,Ltd.
| Country | Taiwan |
| Founded | 2003 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Yi Xing Lin |
Contact Details
Address: No. 3, Yuanyuan Street Taipei, 11503 Taiwan | |
| Phone | 886 2 6616 0001 |
| Website | welgene.com.tw |
Stock Details
| Ticker Symbol | 6661 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006661002 |
| SIC Code | 8734 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yi Xing Lin | GM and Director |
| Ying-Ren Chen | Accounting Supervisor |